FURTHER CHANGES ARE COMING to the in vitro diagnostics (IVD) marketplace. On October 19, Abbott Laboratories, Inc., announced that it would separate into two publicly-traded companies sometime in 2012.
One business will be the medical devices and diagnostics business. It will have about $22 billion in annual sales. Of this total, about $4 billion comes from the